Volume 64, Issue 6 pp. 415-423
Human Cancer
Full Access

Expression of leukocyte cell adhesion molecules on gastric carcinomas: Possible involvement of lfa-3 expression in the development of distant metastases

Barbara Mayer

Corresponding Author

Barbara Mayer

Department of Surgery, Grosshadem Clinic, Munich, Germany

Department of Surgery, Klinikum Grosshadern, University of Munich, Marchioninistr. 15,81377 Munich, Germany. Fax: 0049-89-7004418Search for more papers by this author
Claudia Lorenz

Claudia Lorenz

Department of Surgery, Grosshadem Clinic, Munich, Germany

Search for more papers by this author
Rudolf Babic

Rudolf Babic

Institute of Pathology, Munich, Germany

Search for more papers by this author
Karl W. Jauch

Karl W. Jauch

Department of Surgery, Grosshadem Clinic, Munich, Germany

Search for more papers by this author
Friedrich W. Schildberg

Friedrich W. Schildberg

Department of Surgery, Grosshadem Clinic, Munich, Germany

Search for more papers by this author
Ilona Funke

Ilona Funke

Department of Surgery, Grosshadem Clinic, Munich, Germany

Search for more papers by this author
Judith P. Johnson

Judith P. Johnson

Institute for Immunology, University of Munich, Munich, Germany

Search for more papers by this author
First published: 20 December 1995
Citations: 18

Abstract

Expression of the cell adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) was examined on primary gastric carcinomas, autologous benign mucosa and metastatic lesions. Although ICAM-1 was never observed on benign gastric epithelium, even in the presence of chronic inflammation and a strong leukocyte infiltrate, 38% (26/69) of the primary tumors expressed this molecule. ICAM-1 was restricted to differentiated tumors and correlated with the presence of leukocytes and the absence of vessel invasion. The ICAM-1 expression pattern of metastatic lesions reflected that of the primary tumor, suggesting that most tumors retain the non-inducible phenotype seen in normal mucosa while some become cytokine-sensitive. ICAM-1 expression showed no correlation with tumor relapse or survival. LFA-3 was absent from 8% (4/49) of the primary tumors and reduced (e.g., ± 50% positive cells) in 33% (16/49). Expression of LFA-3 by more than 50% of the tumor cells correlated with cellular dedifferentiation (G3, G4), histologically detectable vessel invasion, tumor recurrence and decreased survival time. Primary tumors and metastases in draining lymph nodes demonstrated a broad range of LFA-3 expression. In contrast, distant metastases (liver and peritoneum) had uniformly high frequencies of LFA-3-positive cells, suggesting a selective advantage for these cells in the establishment of distant metastases. © 1995 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.